Overview

  • Product name
    Anti-ZFYVE19 antibody [EPR9789]
    See all ZFYVE19 primary antibodies
  • Description
    Rabbit monoclonal [EPR9789] to ZFYVE19
  • Host species
    Rabbit
  • Tested applications
    Suitable for: WB, Flow Cytmore details
    Unsuitable for: ICC/IF,IHC-P or IP
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide, coresponding to residues in Human ZFYVE19 (UniProt: Q96K21).

  • Positive control
    • MCF7, BxPC3, Raji and Human fetal liver lysates; MCF7 cells.
  • General notes

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

     

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents

    This product is a recombinant rabbit monoclonal antibody.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Store at -20ºC.
  • Storage buffer
    Preservative: 0.01% Sodium azide
    Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
  • Purity
    Tissue culture supernatant
  • Clonality
    Monoclonal
  • Clone number
    EPR9789
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab155085 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 52 kDa.
Flow Cyt 1/10 - 1/100.

ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.

 

  • Application notes
    Is unsuitable for ICC/IF,IHC-P or IP.
  • Target

    • Tissue specificity
      Detected in brain, heart, skeletal muscle, kidney and liver.
    • Involvement in disease
      Note=A chromosomal aberration involving ZFYVE19 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with MLL/HRX.
    • Sequence similarities
      Contains 1 FYVE-type zinc finger.
    • Post-translational
      modifications
      Phosphorylated upon DNA damage, probably by ATM or ATR.
    • Information by UniProt
    • Database links
    • Alternative names
      • Abscission/NoCut checkpoint regulator antibody
      • ANCHR antibody
      • MLL partner containing FYVE domain antibody
      • MPFYVE antibody
      • ZFY19_HUMAN antibody
      • ZFYVE 19 antibody
      • Zfyve19 antibody
      • Zinc finger FYVE domain containing protein 19 antibody
      • Zinc finger FYVE domain-containing protein 19 antibody
      • Zinc finger FYVE type containing 19 antibody
      • Zinc finger, FYVE domain containing 19 antibody
      see all

    Images

    • Flow cytometric analysis of permeabilized MCF7 cells labeling ZFYVE19 with ab155085 at 1/10 dilution (red) compared with a Rabbit IgG negative control (green).
    • All lanes : Anti-ZFYVE19 antibody [EPR9789] (ab155085) at 1/1000 dilution

      Lane 1 : MCF7 cell lysate
      Lane 2 : BxPC3 cell lysate
      Lane 3 : Raji cell lysate
      Lane 4 : Human fetal liver lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat anti-rabbit HRP at 1/2000 dilution

      Predicted band size: 52 kDa

    References

    ab155085 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab155085.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up